News

An investigational cancer drug called ADI-PEG 20 that starves tumors of their energy supply also shows evidence of improving whole-body metabolism, according to a new study performed in mice.

Research suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.

According to a study, a drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease.

To stop acute myeloid leukemia, targeting neighboring bone cells could be a better strategy than directly targeting the cells that give rise to the disease.

A new drug that targets the cytokine storm associated with severe COVID-19 disease has passed its phase two clinical trial.

A new study from researchers at Beth Israel Deaconess Medical Center (BIDMC) suggests that some of the adverse events reported in the COVID-19 vaccine trials are attributable to the placebo effect.

A theoretical framework has been published that assesses the impact of various vaccination strategies on the rate of emergence for new variants.

Researchers have identified a mechanism by which Zika virus can escape detection by host cells, offering a new target for therapeutics.

A research team has discovered that orally administrated colloidal bismuth subcitrate together with N-acetyl cysteine could be a broad-spectrum anti-coronavirus cocktail therapy.

A preliminary study of 106 participants with “wet” age-related macular degeneration suggests that as many as a third of those with the disease may be able to safely stop eye injections without experiencing further vision loss.